Treatment for breast cancer can damage the heart. Proton therapy can be a safer alternative for some patients.
It wasn’t long after Jenny Ebner was diagnosed with breast cancer that she learned she’d need radiation therapy. And since her cancer was on her left side, she wanted to find a treatment that would spare her heart. She has, after all, been married for 21 years and is the mother of two sons. She needs that heart to love her family and live her life in southern Oregon.
Originally diagnosed in May 2017, Ebner had eight rounds of chemotherapy and surgery before she met with a radiation oncologist in Portland to evaluate further treatment.
“We knew radiation was likely,” Ebner said. “And it didn’t take long to realize the risks. Because my cancer was on my left side, traditional radiation would pass through my chest wall and irradiate my heart and healthy lung.”
After the initial meeting in Portland, Ebner and her husband went back to her oncologist and expressed concern about the effect of radiation on her heart. That’s when her doctor suggested the Seattle Cancer Care Alliance Proton Therapy Center.
Most Read Stories
- 'Unwanted subject': What led a Kirkland yogurt shop to call police on a black man | Danny Westneat
- Dispute arises among U.S. pilots on Boeing 737 MAX system linked to Lion Air crash
- The 111th Apple Cup: These Cougs feel different. Husky fans should feel nervous. | Matt Calkins
- Puget Sound orcas are in town, chasing chum and wowing ferry riders WATCH
- Mike Leach's tweet of doctored Obama video cost WSU $1.6 million in donations
At the Proton Therapy Center, Ebner and her husband met L. Christine Fang, M.D., a radiation oncologist, who reviewed her options.
“The classic trials that show radiation leading to a decrease in local recurrence and breast cancer mortality, also show a corresponding increase in heart-related mortality,” Fang says. “Radiation can cause accelerated coronary artery disease that leads to cardiac morbidity and mortality.”
On the other hand, proton beam therapy can treat just the targeted area. This allows the radiation oncologist to better spare the heart and surrounding tissue in some women. And this, of course, is good news for Ebner’s long-term health.
“The primary advantage of proton beam therapy is its superior dose distribution over X-ray therapy,” says Dr. Fang. “Once a proton beam has traversed and treated the target, its dose drops to zero, thus not depositing any exit dose to healthy tissue.”
Ebner and her husband were impressed by the technology but also the treatment they received. “Dr. Fang was so knowledgeable and gave us this great hope that this was the safest treatment I could be receiving for my situation,” Ebner says. “She also showed us the beam’s path so we could see with our own eyes that my heart was spared the effects of radiation.”
With the decision made, Ebner decided to relocate to Seattle for her 36 treatments. Furthermore, she decided to home school the boys and bring them along with her. Her husband, who had to work, joined them when he could. Ebner found the treatment itself to be an easy process that only took a few minutes each day and had minimal side effects. The rest of the time she and the kids were able to enjoy the sights and do things around Seattle.
Ebner finished treatment the day before her 40th birthday and it seemed like a great day to wrap up her active breast cancer treatment. Now she is disease free and back to normal life in southern Oregon with her boys, who are 14 and 9. Last summer the family took a week-long trip to Alaska and Ebner was able to hike right along with her husband and kids. She’s happy life is settling down and that they are returning to their normal routines, and she’s still grateful for the care she received at SCCA Proton Therapy Center.
SCCA Proton Therapy Center uses precisely targeted radiation to treat cancer while preserving surrounding healthy tissue and reducing the potential for side effects. Protons are beneficial in treating patients with a broad range of tumors, including brain, breast, lung and prostate.